Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

Stock Information for Mustang Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Mustang Bio Inc.

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
Mustang Bio Announces Closing of $4 Million Public Offering
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
Mustang Bio Announces Pricing of $4 Million Public Offering
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
Avenue Therapeutics Announces Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.